BNO 1055
DEAD

Serial Number

77302920

Owner

BIONORICA AG

Attorney

Kenneth F. Florek

Filing Date

Oct 12, 2007

Add to watchlist:

No watchlists yet
View on USPTO

BNO 1055 Trademark

Serial Number: 77302920 • Registration: 3578606

BNO 1055 is a trademark filed by BIONORICA AG on October 12, 2007. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). The application is currently no longer active.

Owner Contact Info

BIONORICA AG (65 trademarks)

KERSCHENSTEINERSTRASSE 11-15
92318 NEUMARKT , DE

Entity Type: 09

Trademark Details

Filing Date

October 12, 2007

Registration Date

February 24, 2009

Published for Opposition

December 9, 2008

Cancellation Date

September 25, 2015

Goods & Services

Plant extracts, tinctures and flavourings in liquid, solid or gaseous form or non-nutritional purposes in food used as flavorings and seasonings, herbal teas for food purposes; plant extracts used as flavouring in liquid, solid or gaseous form for foodstuffs, food supplements and food; foods and dietetic foods, namely, ready to eat cereal derived food bars; flavourings in liquid, solid or gaseous form for the manufacture of edible cosmetics and food; herbal teas

Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities, neoplasia, breast neoplasm, breast cancer, mamma, mastopathy, mastodynia, premenstrual syndrome, climacteric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, vaginal discomfort due to menopausal atrophic changes, climactic sleep disturbances, depressive moods, osteoprotectio, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, neprholithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteo arthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, muscularskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, stimulant, and tranquilizer; hemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; menstruation circulation regulating tablets; hormone preparations, hormone replacement medication; pharmaceutical preparations for sensory organs, namely, for use in ophthalmology, otolaryngology and dermatology; pharmaceutical preparations for regulation and strengthening of the immune system; pharmaceutical preparations for treating temporary relief of occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of dental bleaching gels, gum balms, medicated dental floss, medicated dental tapes, medicated dental ribbons, medicated teeth whitener gels, medicated toothpicks, fluoride chewing gum and chewable tablets for disclosing dental plaque and tartar; preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria, caries, diagnostic reagents for detecting derivatives from caries-causal bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; medicated mouth sprays and desensitizers; plant extracts for veterinary and pharmaceutical purposes; sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for hygiene purposes; sanitary preparations for the treatment, cleaning and protection of the skin; dietary supplements in the form of tablets, drops, capsules, extract preparations, balms or in liquid form, containing plant extracts; dietetic substances adapted for medical use in the form of tablets, drops, capsules, extract preparations, balms or in liquid form; food for medically restricted diets, food for diabetics, food supplements containing plant extracts, food supplements derived from plants or plant extracts, all aforesaid goods in the form of tablets, drops, capsules, extract preparations, balms or in liquid form; vitamin and mineral supplements; food supplements, namely, herbal teas for medicinal purposes and medicinal teas; nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; dietetic food supplements; dietary supplements; food supplements and dietary food supplements; mineral food supplements, food supplements based on amino acids, minerals and/or trace elements; food supplements; medical plasters; materials for dressings, namely, gauze and bandages; all purpose disinfectants; material for stopping teeth; dental wax

Essential oils for use in the manufacture of cosmetics; hair lotions; dentifrices

Vegetable extracts and tinctures in liquid, solid or gaseous form for manufacture of cosmetics, food and nutritional additives; plant extracts, namely, cimicifuga racemosa used in the manufacture of pharmaceutical preparations, bulk pharmaceutical preparations, and raw materials for pharmaceutical preparations

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 25, 2015 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 27, 2010 TCCA
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 28, 2009 COC.
ASSIGNED TO PARALEGAL
Apr 23, 2009 PLGL
SEC 7 REQUEST FILED
Mar 30, 2009 AMD7
PAPER RECEIVED
Mar 30, 2009 MAIL
REGISTERED-PRINCIPAL REGISTER
Feb 24, 2009 R.PR
PUBLISHED FOR OPPOSITION
Dec 9, 2008 PUBO
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 25, 2008 EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 25, 2008 EPPA
NOTICE OF PUBLICATION
Nov 19, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 6, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2008 CNSA
EXAMINERS AMENDMENT MAILED
Sep 29, 2008 CNEA
EXAMINER'S AMENDMENT ENTERED
Sep 29, 2008 XAEC
EXAMINERS AMENDMENT -WRITTEN
Sep 29, 2008 CNEA
PRIORITY ACTION MAILED
Sep 29, 2008 CPRA
PRIORITY ACTION WRITTEN
Sep 29, 2008 CPRA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 15, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 29, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 20, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2008 CNSA
AMENDMENT FROM APPLICANT ENTERED
Jun 4, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2008 CRFA
ASSIGNED TO LIE
Jun 4, 2008 ALIE
PAPER RECEIVED
Jun 2, 2008 MAIL
NON-FINAL ACTION MAILED
Dec 11, 2007 CNRT
NON-FINAL ACTION WRITTEN
Dec 10, 2007 CNRT
ASSIGNED TO EXAMINER
Dec 10, 2007 DOCK
NEW APPLICATION ENTERED
Oct 17, 2007 NWAP